Selective central nervous system tropism of primary central nervous system lymphoma

International Journal of Clinical and Experimental Pathology

Volumn 3, Issue 8, 2010, Pages 763-767

  Jiang, Liuyan ^a   Marlow, Laura A ^a   Cooper, Simon J ^a   Roemeling, Christina V ^a   Menke, David M ^a   Copland, John A ^a   Tun, Han W ^a  

^a MAYO CLINIC   (United States)

Author keywords

Central nervous system; Lymphoma; Tropism

Indexed keywords

OSTEOPONTIN; TUMOR MARKER;

ADULT; ANIMAL; ARTICLE; BRAIN; BRAIN TUMOR; CANCER INVASION; CANCER TRANSPLANTATION; CASE REPORT; CELL MOTION; CENTRAL NERVOUS SYSTEM TUMOR; FATALITY; FEMALE; HUMAN; IMMUNOLOGY; LARGE CELL LYMPHOMA; LYMPHOCYTE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; VASCULARIZATION; XENOGRAFT;

ADULT; ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; LYMPHOCYTES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OSTEOPONTIN; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953148896     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Deangelis LM, and Iwamoto FM. An update on therapy of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2006;20:1267-85.
2. Anthony, I.C., D.H. Crawford, and J.E. Bell, B lymphocytes in the normal brain: contrasts with HIVassociated lymphoid infiltrates and lymphomas. Brain, 2003;126(Pt 5):1058-67.
3. Camilleri-Broet S, Criniere E, Broet P, Delwail V, Mokhtari K, Moreau A, Kujas M, Raphaël M, Iraqi W, Sautes-Fridman C, Colombat P, Hoang-Xuan K, Martin A. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood, 2006. 107:190-6.
4. Braaten KM, Betensky RA, de Leval L, Okada Y, Hochberg FH, Louis DN, Harris NL, Batchelor TT. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res, 2003;9:1063-9.
5. Larocca LM, Capello D, Rinelli A, Nori S, Antinori A, Gloghini A, Cingolani A, Migliazza A, Saglio G, Cammilleri-Broet S, Raphael M, Carbone A, Gaidano G. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood, 1998; 92:1011-9.
6. Imai H, Kajimoto K, Taniwaki M, Miura I, Hatta Y, Hashizume Y, Watanabe M, Shiraishi T, Nakamura S. Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: a report of five cases. Pathol Int, 2004;54:231-6.
7. Tun HW, Personett D, Baskerville KA, Menke DM, Jaeckle KA, Kreinest P, Edenfield B, Zubair AC, O'Neill BP, Lai WR, Park PJ, McKinney M. Pathway analysis of primary central nervous system lymphoma. Blood, 2008;111:3200-10.
8. Mrugala MM, Rubenstein JL, Ponzoni M, Batchelor TT. Insights into the biology of primary central nervous system lymphoma. Curr Oncol Rep, 2009;11:73-80.
9. Rubenstein JL, Shen A, Batchelor TT, Kadoch C, Treseler P, Shuman MA. Differential gene expression in central nervous system lymphoma. Blood, 2009. 113:266-7; author reply 267-8.
10. Tun, H., Differential gene expression of central nervous system lymphoma. Blood, 2009;113:267.
11. Smith JR, Braziel RM, Paoletti S, Lipp M, Uguccioni M, Rosenbaum JT. Expression of B-cellattracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood, 2003;101:815-21.